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Objective: The aim of this study was to assess which of the basal ovarian reserve markers provides the best
reflection of the changes occurring in ovarian function over time (i.e., reproductive aging).
Design: Prospective longitudinal study.
Setting: Healthy volunteers in an academic research center.
Patient(s): Eighty-one women with normal reproductive performance during the course of their lives were
longitudinally assessed. In this select group of women, becoming chronologically older was considered as a proxy
variable for becoming older from a reproductive point of view.
Intervention(s): The women were assessed twice, with on average a 4-year interval (T1 and T2). The number of
antral follicles on ultrasound (AFC) and blood levels of antimüllerian hormone (AMH), FSH, inhibin B, and E2
were assessed.
Main Outcome Measure(s): Longitudinal changes of the markers mentioned and the consistency of these
parameters over time.
Result(s): The mean ages at T1 and T2 were 39.6 and 43.6 years, respectively. Although AFC was strongly
associated with age in a cross-sectional fashion, it did not change over time. The AMH, FSH, and inhibin B levels
showed a significant change over time, in contrast to E2 levels. The AMH and AFC were highly correlated with
age both at T1 and T2, whereas FSH and inhibin B predominantly changed in women more than 40 years of age.
To assess the consistency of these parameters over time, we investigated whether a woman’s individual level
above or below the mean of her age group at T1 remained above or below the mean of her age group at T2. Serum
AMH concentrations showed the best consistency, with AFC as second best. The FSH and inhibin B showed only
modest consistency, whereas E2 showed no consistency at all.
Conclusion(s): These results indicate that serum AMH represents the best endocrine marker to assess the
age-related decline of reproductive capacity. (Fertil Steril 2005;83:979–87. ©2005 by American Society for
Reproductive Medicine.)
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aith increasing age there is a decline in a woman’s repro-
uctive function, which is assumed to be determined by the
ecline of the ovarian follicle pool and the quality of the
ocytes within (ovarian reserve) (1). Menopause is reached
t a median age of 51 years, when the follicle pool is
almost) depleted (2). Given the considerable individual
ariability in age at menopause (3), it is plausible that the
rocess of follicle decline shows a comparable variability.
eceived May 26, 2004; revised and accepted November 30, 2004.
eprint requests: Ilse van Rooij, Ph.D., Department of Reproductive
Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584
CX Utrecht, The Netherlands (FAX: 31-30-2505433; E-mail: i.vanrooij@dazu.nl).
015-0282/05/$30.00
oi:10.1016/j.fertnstert.2004.11.029 Copyright ©2005 American Socence, for women of similar ages, large differences in their
varian reserve are likely to exist.
Various endocrinological and sonographic markers have
een used to assess the ovarian reserve. First, an increase in
SH levels in women over 35 years was observed (4).
ubsequently, it was shown that inhibin B levels diminished
ith advancing age, presumably due to a reduction of the
ecruited cohort of the antral follicle pool during the follic-
lar phase of the cycle (5–7). In addition, changes in E2
evels have been described in women of advanced reproduc-
ive age. Both an increase (8) and a decline (9) were re-
orted. The size of the antral follicle cohort can be directly
ssessed by ultrasound (10), and the observed pattern of its
ecline appears to correspond with that of the primordial
979Fertility and Sterility Vol. 83, No. 4, April 2005
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uollicle pool (11). Recently, serum antimüllerian hormone
AMH) levels have been introduced as a novel measure of
varian reserve. AMH is a product of granulosa cells of the
reantral and antral follicles (12, 13). Serum AMH levels
ecline with age and are related to the number of antral
ollicles and to the ovarian response after ovarian hyper-
timulation (14–18).
Previously, we have shown in a cross-sectional study that
he number of antral follicles assessed by ultrasonography
AFC) better reflects chronological age in normal women
ith regular cycles and proven normal fertility (19), com-
ared to other ovarian reserve tests. Because these women
ere selected on the basis of normal reproductive perfor-
ance during the course of their lives, it was assumed that
heir ovarian function reflects the gradual age-related decline
f normal reproductive capacity. Therefore, their chronolog-
cal age was considered to approximate their reproductive
ge. However, as indicated in such a population the variation
f reproductive capacity in women of the same age category
s likely to exist.
This previous study was the beginning of a continuing
ongitudinal study. Women were asked to return every 4
ears for a new assessment of their ovarian reserve. With
uch a design, it is possible to study changes in ovarian
eserve markers in a prospective manner in individual
omen. Because the same assumptions were made for the
ongitudinal part of this study, becoming 4 years older in
hronological age is considered to approximate an increase
f 4 years in reproductive age for these women with proven
ertility. This present study was designed to assess the
hange in levels and values of ovarian reserve over time. The
im of the study was to determine which of the ovarian
eserve tests presently available best reflects the process of
eproductive aging in individual women.
ATERIALS AND METHODS
ubjects
n 1996 and 1997 female volunteers were recruited for a
ongitudinal cohort study through advertisement in local
ewspapers. The inclusion criteria have been described be-
ore (11, 19). In short, the women had to be 25–46 years of
ge and to have a regular menstrual cycle of 21–35 days.
hey had to have a proven natural fertility, which was
efined as having established one or more pregnancies
ithin 1 year after stopping contraception. This pregnancy
esulted in a normal delivery at term. Moreover, they never
ad ovarian surgery or ovarian abnormalities and they had
topped hormonal contraception for 3 months or more before
ntering the study.
Of the 162 volunteers included in 1996–1997 (11, 19), 82
greed to continue. The remaining 80 women did not par-
icipate in the longitudinal part of this study because they did
ot want to stop hormonal contraception (n  10), were
regnant or breastfeeding (n  3), had intercurrent disease c
980 van Rooij et al. Serum AMH reflects female reproductivn  3), had no time (n  8), or had moved away from the
rea (n  37). For 19 volunteers the reason for not partici-
ating was not known. The women not taking part in the
ollow-up study were on average 4 years younger than the
omen who did participate.
The Institutional Review Board approved of the study and
ritten informed consent was obtained from all participants.
he volunteers received monetary compensation for partic-
pating.
tudy Design
he 82 women participating in this longitudinal study were
ested at T1 (1996/1997) and at T2 (2001) during the early
ollicular phase of the menstrual cycle (cycle days 2, 3, or 4).
f at T2 no menstrual period had taken place during the past
months because menopausal transition had been reached, a
isit was planned at the woman’s convenience. During both
isits a transvaginal ultrasound was performed using a 7.5-
Hz probe on a Toshiba Capasee SSA-220A (Toshiba Med-
cal Systems Europe BV, Zoetermeer, The Netherlands). At
1 the ultrasound was performed by G.J.S. and at T2 by
.A.J.R. The number of antral follicles was assessed and all
ollicles up to 10 mm were included in the analysis, as
escribed previously (11).
During the same visit blood was drawn. Serum and plasma
ere separated and stored at 20°C for later estimation of
evels of AMH, FSH, inhibin B, and E2. The plasma and
erum samples collected at T1 and T2 of each volunteer were
ssessed in the same assay run.
Some of the women reached menopausal transition, be-
ause cycle irregularity occurred after these women had
ormal regular cycles when they were included at baseline.
here is no available uniform definition for menopausal
ransition, although recently some definitions based on in-
reasing variability in cycle length have been proposed (20,
1). We defined menopausal transition in two ways. The
ean cycle length is between 21 and 35 days, but in the last
alf year the next cycle is not predictable within 7 days. Or
he mean cycle length is 21 or 35 days in the last half
ear.
None of the women in the study used hormonal replace-
ent therapy (HT) for menopausal symptoms. Two women
topped hormonal contraception 3 months before inclusion.
hey regained regular cycles and continued to do so for 6
onths.
ssays
evels of FSH and E2 were measured in plasma with the
xSYM immunoanalyzer (Abbott Laboratories, Abbott
ark, IL). The World Health Organization Second Interna-
ional Reference Preparation for human FSH (78/549) was
sed as a standard for the FSH assay. For FSH, interassay
oefficients of variation were found to be 5.7%, 5.7%, and
e decline Vol. 83, No. 4, April 2005
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F.8% at the levels of 5, 26, and 79 IU/L, respectively (n 
0). The E2 assay has been standardized to gas chromatog-
aphy/mass spectrometry. The interassay variation of the E2
ssay at 185, 330, and 1,152 pmol/L was 12.9%, 7.8%, and
.1%, respectively (n  80).
Serum inhibin B levels were measured using an immu-
oenzymometric assay (Serotec, Oxford, United Kingdom)
s described by Groome et al. (22). Interassay coefficients of
ariation were 6.6% and 6.0% at 110 and 770 pg/mL. An
ltrasensitive immunoenzymometric assay (Immunotech-
oulter, Marseille, France) was used for the estimation of
MH (23). The limit of detection (defined as blank  3SD)
as 0.05 g/L. Intra- and interassay coefficients of variation
ere 5% and 8%. Long-term storage (2 years) of
lood samples at20°C before assessment of AMH levels is
elieved to lead to artificially increased levels (24). How-
ver, these suggestions were based on studies with the Bos-
on assay (24). For the Coulter assay as applied in this study,
uch measurement errors have been excluded as shown else-
here (14).
tatistical Analysis
ata were analyzed with SPSS 10.1 (SPSS Inc., Chicago,
L) and presented as mean (SD) if normally distributed or
edian (10th–90th percentiles) if not normally distributed.
utcomes of the ovarian reserve test with an interval of
pproximately 4 years (T1 and T2) were compared using the
ilcoxon signed rank test.
Because the time interval between T1 and T2 ranged from
to 5 years, the change per year was calculated ([value T2
alue T1]/time interval T2 T1) for every woman. The mean
hange per year with 95% confidence interval around the
ean of each test is given per arbitrary age classes, with age
utoff levels assessed at T1. The significance of the mean
hange was tested by Student’s t-test.
The associations between the results of the ovarian reserve
ests and age both at T1 and T2 were assessed by a quadratic
egression line. If the quadratic regression term on T1 or T2
as significant, a restricted cubic spline was fitted to de-
cribe the relation (25), otherwise a linear relation was
ssumed. All associations between markers and age were
ssessed using Spearman correlations.
The analyses mentioned thus far only evaluated mean
hanges in groups of women. The important question, how-
ver, is: what happens in individual women? Most likely
hey demonstrate considerable variations above and below
he mean. For reliable individual predictions it is important
o know whether or not these variations remain consistent
uring two or more observations over time. Therefore, we
nvestigated whether an individual’s level above (below) the
ean level for her age group at T1 remained above (below)
he mean level for her age group at T2. The same rationale
as been described by Burger et al. (26). t
ertility and SterilityBecause we had only two measurements per woman we
ade use of the so-called partial correlation coefficient anal-
sis (27). The longitudinal setting leads to a slight adaptation
f the procedure, in that we corrected the markers at T1 and
2 separately for age at that time and afterward calculated
he correlation coefficient. Thus, the individual value at T1
inus the group mean value (on the regression line) for that
articular age (the residual) is correlated with the residual at
2 (individual value at T2 minus the group mean value for
ge at T2). If this correlation is high, the ovarian reserve test
s a potentially useful marker for declining ovarian perfor-
ance because the observation at T1 correctly predicts the
evel at T2.
ESULTS
ecause no serum sample was available from one woman at
1, 81 of the 82 women could be analyzed. Mean (SD) age
f the women was 39.6 (5.0) years at T1 and 43.6 (4.9) years
t T2. The mean (range) time interval between T1 and T2 was
.9 (3.0–4.9) years. A total of 67 volunteers still had a
egular cycle at T2, but 14 women had entered the meno-
ausal transition.
At T2 the median serum AMH level was significantly
ower than at T1 (Table 1). Surprisingly, the AFC remained
he same over time. The FSH levels increased significantly,
hereas the inhibin B levels significantly declined and the E2
evels did not change. The changes per year of each ovarian
eserve marker were assessed in the groups according to age
lass (Table 2). AMH showed a highly significant change in
he two highest age classes and a borderline significant
hange in the youngest age group. The AFC, inhibin B, and
SH levels only exhibited a significant yearly change per
ear in women over 40 years of age. This was more marked
or FSH and inhibin B, the levels of which considerably
hanged when age exceeded 40 years. The E2 levels did not
how any significant change.
Figure 1 shows the relationships of the ovarian reserve
arkers with age at T1 and at T2. For FSH it was necessary
o use a fitted line to describe the relation with age at T2
hen linear regression could not be used. For reasons of
omparison a fitted line was used at T1. The antral follicle
ount showed the highest correlation with age at both time
oints, followed by serum AMH. The regression line of AFC
ssessed at T2 was shifted in a parallel fashion and was
ituated above the line representing the relationship with age
t T1, indicating that more antral follicles were counted at T2.
t T1 FSH increased slightly with age, but at T2 this increase
as substantial at more than 40 years of age. Inhibin B
howed a significant association with age at T2, but not at T1.
n contrast, E2 showed only a significant relation with age on
1, which disappeared at T2.
The correlation of the residuals for all markers is shown in
able 3. The AMH showed the highest correlation betweenhe age-adjusted values at T1 and T2. Although AFC showed
981
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lo decline over time, the residuals over time were highly
orrelated. The correlation of the residuals of FSH and
nhibin B were significant, although clearly lower than for
MH and AFC. The residuals of E2 at T1 and T2 were not
orrelated.
ISCUSSION
he prevailing concept of female reproductive aging sug-
ests that the decline of the oocyte/follicle pool determines
he age-dependent loss of female fertility (1). Because chro-
ological age at the final stage of reproductive aging (i.e., the
ccurrence of menopause) shows a considerable individual
ariation, it is most likely that women differ with regard to
he status of the oocyte/follicle pool at a given age. Women
aintain a regular ovulatory pattern with (almost) normal E2
nd P levels for years after they have become infertile (1).
ecause it is not feasible to directly assess the oocyte/follicle
ool, endocrinological and sonographic markers are used as
n indirect measure of the oocyte/follicle pool.
In the current study we evaluated and compared the avail-
ble basal ovarian reserve tests in a population of women
ith normal reproductive performance during the course of
heir lives. In such women the longitudinal changes in ovar-
an reproductive function during the follow-up period are
ikely to reflect the normal physiological decline of female
ecundity. Chronological age, therefore, was taken as the
roxy-variable of reproductive decline and the elapse of
ome 4 years is considered to be accompanied by a decline
n reproductive capacity (1, 11).
The requirements for the ideal marker reflecting the de-
line of reproductive function are summarized in Table 4.
irst, it must be biologically plausible that the marker is
elated to the extent of the oocyte/follicle pool. Second, the
arker should be clearly associated with age. Third, it
hould demonstrate a change over time, preferably from
pproximately 30 until 50 years of age and not only during
r just before the episode of menopausal transition. Most
TABLE 1
Comparison of ovarian reserve tests over time in
mean time interval 4 years).
T1
AMH (g/L) 1.2 (0.1–3.0)
AFC (n) 6 (2–16)
FSH (IU/L) 7.8 (4.9–12.7)
Inhibin B (ng/L) 104 (14–160)
E2 (pmol/L) 180 (98–353)
Note: Values are median (10th–90th) percentiles. See text
a Wilcoxon signed rank test.
van Rooij. Serum AMH reflects female reproductive decline. Fertil Steril 2005.mportant, the individual variation from the mean should be u
982 van Rooij et al. Serum AMH reflects female reproductivonsistent, that is, the level of an individual above or below
he mean at a certain age (the residual value) should remain
he same at subsequent ages.
The biological plausibility of the investigated markers is
o be judged on their ability to reflect the entire follicle pool.
n contrast to AFC and inhibin B (7, 11), AMH may not only
eflect the number of early and developing antral follicles,
ut also earlier stages of follicle development, as was shown
oth in animal and human studies (12, 13, 28, 29). However,
he contribution of the different follicle stages to the final
erum AMH level is unknown. A recent investigation re-
ealed significantly declining serum AMH levels during
varian hyperstimulation (18), suggesting that FSH stimu-
ates the differentiation and maturation of the antral follicles
o such an extent that they cease to produce AMH, whereas
he smaller follicles continue to do so, albeit that their
maller granulosa cell mass results in lower AMH serum
evels.
The FSH release by the pituitary gland is regulated by
he negative feedback action of inhibins, E2, and other
varian FSH-modulating proteins. Therefore, FSH levels
re an indirect reflection of the number of antral follicles
6). The E2 levels are less a reflection of the number of
ntral follicles, but rather of their growth activity during
he follicular phase (4, 8). On the basis of this reasoning
e attributed the highest biological plausibility to AMH,
ollowed by AFC, inhibin B, FSH, and E2.
With regard to the cross-sectional relationship with age
Fig. 1), AFC correlated somewhat better with age com-
ared to AMH and much better than FSH, inhibin B, and
2 at both times of assessment. Until age 40 years, FSH
nd inhibin B levels were not correlated with age, con-
rming an earlier study reporting on a lack of correlation
f FSH and inhibin B with age in women aged 20 –35
ears (30). At 40 years and even more so at 45 years of
ge, FSH started to increase substantially, and the highest
evels were mainly contributed by women with an irreg-
rmal fertile women (T1 value and T2 value,
T2 P value
a
0.5 (0.0–2.2) .001
6 (0–16) .56
8.7 (5.2–45.7) .001
78 (8–139) .002
155 (87–292) .36
abbreviations.no
forlar cycle. These endocrine changes seem only to occur
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Fertihen follicle numbers are strongly reduced (1) just before
r during the menopausal transition.
These higher FSH and lower inhibin B levels in older
omen at T2 led to a much stronger correlation of these
wo parameters with age, compared to the correlation at
1. At T1 a positive, although low correlation of E2 with
ge was present, corresponding to the higher E2 produc-
ion in older women. This is probably caused by advanced
ollicular growth leading to larger follicles in the early
ollicular phase (31). However, when more women with
n irregular cycle pattern were present in the population
at T2), more variation in E2 levels was present and no
orrelation with age could be detected.
AMH was the only marker of ovarian reserve showing
mean longitudinal decline over time in the total study
opulation as well as in all separate age classes (Table 2).
ven at younger ages a significant decline in AMH levels
s present, confirming earlier findings in which AMH was
he only marker changing longitudinally in younger
omen (14). The FSH levels increased and the inhibin B
evels decreased over time, but the significant changes were
nly seen in women over 40 years of age.
Contrary to our expectations, no longitudinal change
as observed for AFC (Table 1), although a strong cross-
ectional relation between AFC and age was present.
ntral follicles were counted at T1 and T2 by two different
bservers, and the second observer appeared to count
ystematically more follicles, as visualized by the two
arallel regression lines for AFC in Figure 1. An assess-
ent bias due to interobserver variability is one of the
ikely explanations for this finding. However, two sepa-
ate studies have shown that variability among observers
n counting antral follicles is rather modest (32, 33).
oreover, a study by de Vet et al. (14) showed that a
ongitudinal decrease in antral follicle numbers was also
bsent at a mean time interval of 2 years.
This may imply that antral follicle numbers follow a
ecline with age that is different from that suggested by the
ross-sectional data in this study. As observer bias is difficult
o rule out from a practical point of view it may remain
mpossible to decide whether AMH levels really are superior
o antral follicle counts, until use can be made of stored
ltrasound scans on three-dimensional equipment (33). Be-
ause all endocrine markers, including AMH, were assessed
n the same run, their longitudinal change was not influenced
y interassay variations.
The AMH levels showed the best consistency of change in
ndividual women. A high correlation between the residuals
f AMH levels at T1 and T2 was observed (Table 3). The
FC was second best in this regard. Although the number of
ollicles counted did not change over time (Table 1), the
omen maintained the same relative positions with respect
o the mean level of their age group. The residuals of FSH
nd inhibin B levels showed a significant but clearly lowercorrelation.T
983lity and Sterility
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vIn a much larger study with more observations per
omen, a sophisticated analysis was performed on the indi-
idual consistency of FSH and E2 in women during the
FIGURE 1
Spearman correlations of all ovarian reserve tests wit
(blue asterisks and dotted line). (A) Correlation of ant
and at T2 (R  0.65, P.001). (B) Correlation of an
and at T2 (R  0.79, P.001). (C) Correlation of FS
0.60, P.001), for the relation of FSH with age a fitte
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van Rooij. Serum AMH reflects female reproductive decline. Fertil Steril 2005.enopausal transition (26). It was concluded that the resid- i
984 van Rooij et al. Serum AMH reflects female reproductivals of FSH were moderately correlated over time and the
esiduals of E2 only weakly. Information regarding the indi-
idual consistency of inhibin B, AFC, and AMH were lack-
e, at T1 (red circles and continuous line) and T2
lerian hormone with age at T1 (R  0.66, P.001)
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Fation between the residuals is a good cycle-to-cycle
greement. We have indications that the cycle-to-cycle vari-
tion of AMH levels is small in comparison with that of the
ther endocrine markers (van Rooij et al., unpublished ob-
ervations).
Because AMH best fulfilled the criteria imposed, it better
eflected the continuous decline of the oocyte/follicle pool
ith age than the other markers investigated. Because its
erum levels decline in all age classes it appears to be the
est marker of the gradual dwindling of follicle numbers.
ore important, as the changes over time in individuals
how consistency with regard to the mean decline, AMH
ives the most reliable reflection of individual reproductive
ging and is expected to give better predictions with regard
o the extent of decline in the future.
In the previous cross-sectional part of the study AFC
as considered the best marker of reproductive age (19).
erum AMH levels were not included in that analysis, but
ould have come in as second best. Because AFC and
MH are highly correlated, it is plausible that both pro-
ide a good reflection of the declining follicle pool (14,
6, 17). The AFC fulfilled the ovarian reserve marker
haracteristics, except for the decline over time, which
as likely due to interobserver variability. In future lon-
itudinal investigations stored ultrasound images using
hree-dimensional equipment could be used to assess the
umber of follicles over time by a single observer, thus
liminating interobserver variability (33).
Because we considered menopausal transition as part of
FIGURE 1 Continued
van Rooij. Serum AMH reflects female reproductive decline. Fertil Steril 2005.he normal reproductive aging process, we included women s
ertility and Sterilityhose cycle became irregular. Ovarian reserve tests are
ainly useful in women still having regular cycles, as
omen who reach the menopausal transition are already
nfertile for several years (1). When excluding women, who
ad reached the menopausal transition at T2, AMH also best
epresented the change in reproductive capacity with age
results not shown). From Figure 1 it can be deducted that
SH increases only in a late stage and is therefore clinically
ess useful.
The study design on which ovarian reserve parameters
ere followed in a longitudinal fashion has been applied
n a smaller, previous study from another Dutch research
roup (14). In that study a considerably shorter follow-up
eriod was applied and the range of chronological ages of
he volunteers was clearly narrower. The cohort consisted
f relatively young women, which in majority did not
ave proven fertility in the past. As such that group may
ot have represented the best possible approximation of
ormal reproductive decline. In spite of this, the findings
n both studies on AMH and AFC follow the same pattern
nd taken together provide mutual support for the conclu-
ion that AMH best expresses the reproductive decline
ith age. In contrast, in the present study a clear decline
n FSH and inhibin B levels with age was found, albeit in
he later stages of reproductive life when cycle irregular-
ty may already be present.
Serum AMH levels may be of value in clinical practice.
he AMH has been shown to be a predictor of ovarian
esponse in patients undergoing IVF (15, 16), which can be
egarded as a reflection of ovarian reserve (34). With AFC a
imilar prediction of ovarian response was obtained (16). It
ould be useful to investigate whether AMH or AFC could
ifferentiate in the prognosis of women who are normally
enied IVF treatment because of advanced age. Older pa-
ients with a normal response might still perform well in
VF, and AMH or AFC levels have the potential to detect
TABLE 3
Correlation of the residualsa over time (T1
and T2).
Residuals T1 and T2
AMH 0.66b
AFC 0.58b
FSH 0.30b
Inhibin B 0.37b
E2 0.05
Note: Values are Pearson correlation coefficients.
a Residuals are age corrected values of ovarian reserve
markers.
b P.01.
van Rooij. Serum AMH reflects female reproductive decline. Fertil Steril
2005.uch women (35).
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2Another application of the ovarian reserve tests may in-
olve the prediction of cycle irregularity or the final men-
trual period. Due to the large individual variation, a single
easurement of FSH or E2 appears not to be able to reliably
etect the reproductive status of an individual woman (26).
ecause serum AMH levels and the number of antral folli-
les decline more gradually with age, they may better predict
he occurrence of the menopausal transition.
In summary, we consider serum AMH levels to be the best
arker reflecting the decline of reproductive aging. Useful
linical applications of AMH seem feasible.
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